Video |

Novartis strikes back in India - Month in Focus, September 2011

 

Novartis is contesting a key public health safeguard in Indian patent law specifically designed to prevent drug companies from abusively patenting known medicines in Indian Supreme Court.  If successful, the move would have a devastating impact on access to affordable medicines across the developing world, according to MSF.